0001415889-23-012145.txt : 20230811 0001415889-23-012145.hdr.sgml : 20230811 20230811164806 ACCESSION NUMBER: 0001415889-23-012145 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230810 FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOWEN MAXINE CENTRAL INDEX KEY: 0001280044 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 231164854 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aceragen, Inc. CENTRAL INDEX KEY: 0000861838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043072298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 EAGLEVIEW BOULEVARD STREET 2: SUITE 212 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 4843481600 MAIL ADDRESS: STREET 1: 505 EAGLEVIEW BOULEVARD STREET 2: SUITE 212 CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: IDERA PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20050912 FORMER COMPANY: FORMER CONFORMED NAME: HYBRIDON INC DATE OF NAME CHANGE: 19951211 4 1 form4-08112023_080800.xml X0508 4 2023-08-10 0000861838 Aceragen, Inc. ACGN 0001280044 GOWEN MAXINE C/O ACERAGEN, INC. 505 EAGLEVIEW BOULEVARD, SUITE 212 EXTON PA 19341 true false false false 0 Common Stock 2023-08-10 4 S 0 51 0.51 D 0 I By Trust Shares of common stock held in the name Brian Macdonald for Maxine Gowen Trust, for which the Reporting Person is a beneficiary and trustee. /s/ Maxine Gowen 2023-08-11